Email updates

Keep up to date with the latest news and content from BMC Immunology and BioMed Central.

Open Access Highly Accessed Research article

Toll-like receptor 4 (TLR4) expression in human and murine pancreatic beta-cells affects cell viability and insulin homeostasis

Humberto M Garay-Malpartida12, Roberta F Mourão1, Marluce Mantovani13, Icaro A Santos1, Mari C Sogayar13 and Anna C Goldberg145*

Author Affiliations

1 Núcleo de Terapia Celular e Molecular, Universidade de São Paulo, São Paulo, Brasil

2 Escola de Artes, Ciências e Humanidades, Universidade de São Paulo, São Paulo, Brasil

3 Instituto de Química, Departamento de Bioquímica, Universidade de São Paulo, São Paulo, Brasil

4 Instituto de Investigação em Imunologia (iii), Institutos Nacionais de Ciência e Tecnologia, Brasil

5 Hospital Israelita Albert Einstein, São Paulo, Brasil

For all author emails, please log on.

BMC Immunology 2011, 12:18  doi:10.1186/1471-2172-12-18

Published: 28 February 2011

Abstract

Background

Toll-like receptor 4 (TLR4) is widely recognized as an essential element in the triggering of innate immunity, binding pathogen-associated molecules such as Lipopolysaccharide (LPS), and in initiating a cascade of pro-inflammatory events. Evidence for TLR4 expression in non-immune cells, including pancreatic β-cells, has been shown, but, the functional role of TLR4 in the physiology of human pancreatic β-cells is still to be clearly established. We investigated whether TLR4 is present in β-cells purified from freshly isolated human islets and confirmed the results using MIN6 mouse insulinoma cells, by analyzing the effects of TLR4 expression on cell viability and insulin homeostasis.

Results

CD11b positive macrophages were practically absent from isolated human islets obtained from non-diabetic brain-dead donors, and TLR4 mRNA and cell surface expression were restricted to β-cells. A significant loss of cell viability was observed in these β-cells indicating a possible relationship with TLR4 expression. Monitoring gene expression in β-cells exposed for 48h to the prototypical TLR4 ligand LPS showed a concentration-dependent increase in TLR4 and CD14 transcripts and decreased insulin content and secretion. TLR4-positive MIN6 cells were also LPS-responsive, increasing TLR4 and CD14 mRNA levels and decreasing cell viability and insulin content.

Conclusions

Taken together, our data indicate a novel function for TLR4 as a molecule capable of altering homeostasis of pancreatic β-cells.